{
  "docId": "019de076-3deb-7779-9c43-c38f834a1cfd",
  "docSlug": "60ad9a5894e93b6af8b1b5bddd2d87e3",
  "documentTitle": "Fusion Pharmaceuticals | Investor Presentation Deck | 30 slides",
  "authorId": "fusion-pharmaceuticals",
  "authorName": "Fusion Pharmaceuticals",
  "documentKindSlug": "pitchdeck",
  "documentKindLabel": "Pitch deck",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2023-11-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 15,
  "pageCount": 30,
  "prevPage": 14,
  "nextPage": 16,
  "slideType": "solution",
  "function": "present_solution",
  "density": "overcrowded",
  "nDataPoints": 14,
  "notes": "The slide uses a PET scan image to demonstrate selective tumor uptake versus normal tissue, and a table to quantify market opportunity by tumor type.",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de076-3deb-7779-9c43-c38f834a1cfd/15",
  "deckHref": "/decks/019de076-3deb-7779-9c43-c38f834a1cfd",
  "deckJsonHref": "/decks/019de076-3deb-7779-9c43-c38f834a1cfd.json",
  "deckAnchorHref": "/decks/019de076-3deb-7779-9c43-c38f834a1cfd#slide-15",
  "components": [
    {
      "bbox": {
        "h": 0.08,
        "w": 0.8,
        "x": 0.1,
        "y": 0.14
      },
      "kind": "callout",
      "text": "The power of alphas creates the opportunity to explore antibody/ADC oncology targets in new ways",
      "attrs": null,
      "subkind": "primary",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "388fa812-1103-4f73-9b9a-6c02a88a08cc",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.45,
        "w": 0.15,
        "x": 0.38,
        "y": 0.35
      },
      "kind": "image",
      "text": "PET scan showing tumor uptake",
      "attrs": null,
      "subkind": "illustration",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "41192129-3e26-4358-8f78-650205c59f8e",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.15,
        "w": 0.3,
        "x": 0.04,
        "y": 0.6
      },
      "kind": "list",
      "text": "MOA: Alpha particle-based cell kill – NOT based on blocking the IGF-1R pathway; IGF-1R is used only to identify and deliver the alpha emitting payload to the tumor",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "1df3cdc5-a667-4157-9614-5377dfd05141",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.25,
        "w": 0.3,
        "x": 0.04,
        "y": 0.25
      },
      "kind": "list",
      "text": "IGF-1R: Attractive alpha therapeutic delivery mechanism; Over-expressed on the surface of cancer cells; Low expression on surface of normal tissue; Rapidly internalizing receptor to concentrate alpha-particles inside tumor cells",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "d9d6c433-85fd-4b06-bbae-d46303f8f1d5",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.6,
        "w": 0.28,
        "x": 0.68,
        "y": 0.25
      },
      "kind": "table",
      "text": "IGF-1R Expression in Solid Tumors: Ovarian 100%, Bladder 100%, Sarcomas 90%, Head & Neck 62%, Prostate 62%, NSCLC 59%, Pancreatic 57%, Colorectal 50%, Liver 50%, Breast 47%, Small Cell Lung 43%, Esophagus 40%, Renal 36%, ACC 36%",
      "attrs": null,
      "subkind": "data",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "011ac5ce-d397-47d3-84a2-6f79420b9993",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.1,
        "w": 1,
        "x": 0,
        "y": 0.9
      },
      "kind": "title",
      "text": "IGF-1R addresses a large market opportunity in multiple solid tumors",
      "attrs": null,
      "subkind": "action-title",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "8295870c-949b-457c-b857-60077d0bc5c8",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.7,
        "x": 0.03,
        "y": 0.03
      },
      "kind": "title",
      "text": "FPI-1434: Targeting Insulin-like Growth Factor 1 Receptor (IGF-1R)",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "4982330f-7b66-4ed6-821b-e37eaf0c8800",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [
    {
      "name": "List presentation",
      "slug": "list-presentation",
      "agent": null,
      "layer": "slide",
      "matchId": "54535064-37ff-4a67-b295-1b81aaaeb2ac",
      "evidence": "list/bullet components",
      "confidence": 0.8
    }
  ],
  "frameworks": [],
  "arcBeats": [],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}